• All
  • Primary Antibodies
  • Conjugated Antibodies for IF
  • Conjugated Antibodies for FC
  • Secondary Antibodies
  • Antibody Labeling KitsNew
  • ELISA Kits
  • IHC Kits
  • Magnetic Cell Separation Kits
  • Cytokines & Growth Factors
  • Neutralizing/activating Antibodies
  • Nanobody-based Reagents
  • Accessory Products and Kits
  • Fusion Proteins
×
×
Host
0
Species Reactivity
0
Species Reactivity
0
Conjugate
0
Conjugate
0
Compatible Species
0
Conjugate
0

Linsidomine hydrochloride

Linsidomine hydrochloride (SIN-1 chloride) 是莫西多明的代谢产物，具有舒张血管、抑制血小板聚集和抗心绞痛的活性。在心肌缺血-再灌注模型中，Linsidomine hydrochloride 减少心肌坏死和再灌注诱导的内皮功能障碍，与海绵体的作用机制涉及一氧化氮的释放有关。

CAS号

16142-27-1

分子式

C6H11ClN4O2

主要靶点

Others

仅限科研使用

Cat No : CM11744

Print datasheet

Synonyms

SIN-1 chloride

验证数据展示

  • CAS No.: 16142-27-1

    Linsidomine hydrochloride
    CAS#: 16142-27-1

产品信息

Linsidomine hydrochloride is considered as a metabolite of moxidomine, with vasodilation, inhibition of platelet aggregation, and antiangina activity. In myocardial ischemia-reperfusion models, Linsidomine hydrochloride to reduce myocardial necrosis and reperfusion induced endothelial dysfunction is associated with the cavernosal mechanism of action involved in nitric oxide release.

CAS号 16142-27-1
分子式 C6H11ClN4O2
主要靶点 Others
主要通路 其他
分子量 206.63
纯度 99.81%， 此纯度可做参考，具体纯度与批次有关系，可咨询客服
储存条件 Powder: -20°C for 3 years | In solvent: -80°C for 1 year
别名 SIN-1 chloride

体内活性

SIN-1 (chloride) is the active metabolite of molsidomine. SIN-1 (chloride) exhibits a potent vasorelaxant effect and inhibition of platelet aggregation.[1] SIN-1 (chloride) decreases myocardial necrosis and reperfusion-induced endothelial dysfunction in models of myocardial ischemia-reperfusion.[2]

体外活性

SIN-1 decreases myocardial necrosis and reperfusion-induced endothelial dysfunction in models of myocardial ischemia-reperfusion [1][2].

溶解度

H2O:45.0 mg/mL (217.8 mM),Sonification is recommended.,DMSO:22.5 mg/mL (108.9 mM),ultrasonic and warming and heat to 60°C

参考文献

1.Nishikawa M, et al. Inhibition of platelet aggregation and stimulation of guanylate cyclase by an antianginal agent molsidomine and its metabolites. J Pharmacol Exp Ther. 1982;220(1):183-190.
2.Siegfried MR, et al. Cardioprotection and attenuation of endothelial dysfunction by organic nitric oxide donors in myocardial ischemia-reperfusion. J Pharmacol Exp Ther. 1992;260(2):668-675.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
=
×
×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
×
=
×
C1   V1   C2   V2